References
- George R, Ve RS, Vijaya L. Glaucoma in India: estimated burden of disease. J Glaucoma. 2010;19:391–397. doi:10.1097/IJG.0b013e3181c4ac5b.
- The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429–440. doi:10.1016/s0002-9394(00)00538-9
- Leske MC, Heijl A, Hussein M. et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48–56. doi:10.1001/archopht.121.1.48.
- Konstas AG, Maskaleris G, Gratsonidis S, Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye (Lond). 2000;14Pt 5:752–756. doi:10.1038/eye.2000.197.
- Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12:393–398. doi:10.1097/00061198-200310000-00001.
- Sleath BL, Krishnadas R, Cho M. et al. Patient-reported barriers to glaucoma medication access, use, and adherence in southern India. Indian J Ophthalmol. 2009;57:63–68. doi:10.4103/0301-4738.44495.
- Davies IJ, Brown NH, Wen JC. et al. An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle. ClinOphthalmol. 2016;10:1411–1417. doi:10.2147/OPTH.S104751.
- Junqueira DM, Lopes FS, de Souza FC, Dorairaj S, Prata TS. Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma. ClinOphthalmol. 2015;9:367–371. doi:10.2147/OPTH.S78743.
- Sharma R, Singhal D, Shashni A, Agarwal E, Wadhwani M, Dada T. Comparison of eye drop instillation before and after use of drop application strips in glaucoma patients on chronic topical therapy. J Glaucoma. 2016;25:e438–440. doi:10.1097/IJG.0000000000000342.
- Nordmann J-P, Baudouin C, Bron A, et al. Xal-Ease: impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction. Eur J Ophthalmol. 2009;19:949–956. doi:10.1177/112067210901900609.
- Averns H, Hall J, Webley M. Role of opticare eye drop delivery system in patients with rheumatoid arthritis. JRheumatol. 1999;26:2615–2618.
- Hodapp E, Parrish RK, Anderson DR. Clinical Decisions in Glaucoma. St. Louis: Mosby; 1993:52–61.
- Virani S, Rewri P, Dhar M. Difficulties with self instillation of eye drops and its impact on intraocular pressure in glaucoma patients. J Clin Ophthalmol Res. 2015;3:87–90. http://www.jcor.in/text.asp?2015/3/2/87/156592. Accessed August 24, 2020.
- Brown MM, Brown GC, Spaeth GL. Improper topical self-administration of ocular medication among patients with glaucoma. Can J Ophthalmol. 1984;19:2–5.
- Gupta R, Patil B, Shah BM, Bali SJ, Mishra SK, Dada T. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2012;21:189–192. doi:10.1097/IJG.0b013e31820bd2e1.
- Hennessy AL, Katz J, Covert D, Protzko C, Robin AL. Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss. Ophthalmology. 2010;117:2345–2352. doi:10.1016/j.ophtha.2010.03.040.
- Davis SA, Carpenter DM, Blalock SJ. et al. Glaucoma patient preferences for video education on eye drop technique. Optom Vis Sci. 2019;96:325–330. doi:10.1097/OPX.0000000000001375.
- Kass MA, Hodapp E, Gordon M, Kolker AE, Goldberg I. Patient administration of eyedrops: observation. Part II. Ann Ophthalmol. 1982;14:889–893.
- Burns E, Mulley GP. Practical problems with eye-drops among elderly ophthalmology outpatients. Age Ageing. 1992;21:168–170. doi:10.1093/ageing/21.3.168.
- Cronin TH, Kahook MY, Lathrop KL, Noecker RJ. Accuracy and performance of a commercially available Dosing Aid. Br J Ophthalmol. 2007;91:497–499. doi:10.1136/bjo.2006.103093.
- Connor AJ, Severn PS. Force requirements in topical medicine use–the squeezability factor. Eye (Lond). 2011;25:466–469. doi:10.1038/eye.2011.5.